Abstract
Background Early clinical trials of a Clostridium difficile toxoid vaccine show efficacy in preventing C. difficile infection (CDI). The optimal patient group to target for vaccination programmes remains unexplored. This study performed a model-based evaluation of the effectiveness of different CDI vaccination strategies, within the context of existing infection prevention and control strategies such as antimicrobial stewardship. Methods An individual-based transmission model of CDI in a high-risk hospital setting was developed. The model incorporated data on patient movements between the hospital, and catchment populations from the community and long-term care facilities (LTCF), using English national and local level data for model-parameterisation. We evaluated vaccination of: (1) discharged patients who had an CDI-occurrence in the ward; (2) LTCF-residents; (3) Planned elective surgical admissions and (4) All three strategies combined. Results Without vaccination, 10.9 [Interquartile range: 10.0–11.8] patients per 1000 ward admissions developed CDI, of which 31% were ward-acquired. Immunising all three patient groups resulted in a 43% [42–44], reduction of ward-onset CDI on average. Among the strategies restricting vaccination to one target group, vaccinating elective surgical patients proved most effective (35% [34–36] reduction), but least efficient, requiring 146 [133–162] courses to prevent one ICU-onset case. Immunising LTCF residents was most efficient, requiring just 13 [11–16] courses to prevent one case, but considering this only comprised a small group of our hospital population, it only reduced ICU-onset CDI by 9% [8–11]. Vaccination proved most efficient when ward-based transmission rates and antimicrobial consumption were high. Conclusions Strategy success depends on the interaction between hospital and catchment populations, and importantly, consideration of importations of CDI from outside the hospital which we found to substantially impact hospital dynamics. Vaccination may be most desirable in settings or patient groups where levels of broad-spectrum antimicrobial use are high and difficult to reduce.
| Original language | English |
|---|---|
| Pages (from-to) | 5562-5570 |
| Number of pages | 9 |
| Journal | Vaccine |
| Volume | 34 |
| Issue number | 46 |
| DOIs | |
| Publication status | Published - 4 Nov 2016 |
Bibliographical note
Funding Information:EvK was supported by the Healthcare Infection Society major Grant. MJ was supported by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine in partnership with Public Health England (PHE). SD and JR were supported in part by the NIHR HPRU in Modelling Methodology at Imperial College London in partnership with PHE [Grant No. HPRU-2012-10080 ]. MJ was supported by the NIHR HPRU in Immunisation at LSHTM in partnership with PHE [Grant No. HPRU-2012-10096 ]. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR the Department of Health or PHE. The funders had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.
Publisher Copyright:
© 2016 Elsevier Ltd
Keywords
- Clostridium difficile
- Mathematical modelling
- Vaccination